Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and TheranosticsJan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.Neuro-Oncology Advances|December 31, 2024
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with IDH-mutant gliomasNorbert Galldiks, Jan-Michael Werner, Isabelle Stetter, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2019
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRIJan-Michael Werner, Gabriele Stoffels, Thorsten Lichtenstein, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2018
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastomaPhilipp Lohmann, Pantelis Stavrinou, Katharina Lipke, et al.Neuro-Oncology Advances|September 26, 2025
Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastomaIsabelle Stetter, Jan-Michael Werner, Michael Wollring, et al.Journal of Neuro-Oncology|June 18, 2022
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomasJan-Michael Werner, Lena Wolf, Caroline Tscherpel, et al.Scientific Reports|October 22, 2021
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancementJurij Rosen, Gabriele Stoffels, Philipp Lohmann, et al.Neuro-Oncology Advances|December 31, 2025
Assessment of 18F-FET PET-based response in patients with gliomas using the PET RANO 1.0 criteriaGarry Ceccon, Michael Wollring, Isabelle Stetter, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
MRI and 18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness AnalysisJurij Rosen, Jan-Michael Werner, Garry S Ceccon, et al.Neuro-Oncology|October 10, 2022
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PETMichael M Wollring, Jan-Michael Werner, Elena K Bauer, et al.Pageof 6